Search - tctmd.com

Displaying 61 - 80 of 100

Sort: Relevancy | Date

Presentation NY Valves 2024

Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics

Presenter: Amar Krishnaswamy

June 05, 2024

News Conference News ESC Heart Failure 2024

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Michael O'Riordan

May 21, 2024

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

News Daily News

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

L.A. McKeown

May 15, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Conference News ESC Heart Failure 2024

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

Michael O'Riordan

May 13, 2024

News Conference News ESC Heart Failure 2024

Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF

Michael O'Riordan

May 12, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction

Caitlin E. Cox

April 22, 2024

News Conference News ACC 2024

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

L.A. McKeown

April 07, 2024

Presentation ACC 2024

Main Results From The Step-hfpef Dm Trial

Presenter: Mikhail Kosiborod

April 06, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Advertisement

Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Debate Continues on TAVI Choice for Women With Small Annuli

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

Main Results From The Step-hfpef Dm Trial

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content